Leeds Teaching Hospital Trust
Welcome,         Profile    Billing    Logout  
 4 Trials 
7 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Schofield, Callum
HDClarity, NCT02855476: a Multi-site Cerebrospinal Fluid Collection Initiative to Facilitate Therapeutic Development for Huntington's Disease

Recruiting
N/A
2500
Europe, Canada, US, RoW
University College, London, CHDI Foundation, Inc.
Huntington's Disease
05/25
05/25
NCT01574053: Enroll -HD: A Prospective Registry Study in a Global Huntington's Disease Cohort

Recruiting
N/A
35000
Europe, Canada, US, RoW
CHDI Foundation, Inc.
Huntington's Disease
01/62
01/62
Cosgrove, Jeremy
CHIEF PD, NCT04226248: CHIEF-PD (CHolinesterase Inhibitor to prEvent Falls in Parkinson's Disease)

Active, not recruiting
3
600
Europe
Rivastigmine Transdermal System, Placebo Transdermal System
University of Bristol, Royal United Hospitals Bath NHS Foundation Trust
Parkinson Disease
05/24
02/25
HDClarity, NCT02855476: a Multi-site Cerebrospinal Fluid Collection Initiative to Facilitate Therapeutic Development for Huntington's Disease

Recruiting
N/A
2500
Europe, Canada, US, RoW
University College, London, CHDI Foundation, Inc.
Huntington's Disease
05/25
05/25
Squitieri, Ferdinando
HDClarity, NCT02855476: a Multi-site Cerebrospinal Fluid Collection Initiative to Facilitate Therapeutic Development for Huntington's Disease

Recruiting
N/A
2500
Europe, Canada, US, RoW
University College, London, CHDI Foundation, Inc.
Huntington's Disease
05/25
05/25
NCT01574053: Enroll -HD: A Prospective Registry Study in a Global Huntington's Disease Cohort

Recruiting
N/A
35000
Europe, Canada, US, RoW
CHDI Foundation, Inc.
Huntington's Disease
01/62
01/62
Ceccarelli, Consuelo
HDClarity, NCT02855476: a Multi-site Cerebrospinal Fluid Collection Initiative to Facilitate Therapeutic Development for Huntington's Disease

Recruiting
N/A
2500
Europe, Canada, US, RoW
University College, London, CHDI Foundation, Inc.
Huntington's Disease
05/25
05/25

Download Options